Oxazolidinones
- 1 January 2000
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 59 (1) , 7-16
- https://doi.org/10.2165/00003495-200059010-00002
Abstract
The oxazolidinones represent a novel chemical class of synthetic antimicrobial agents. They exhibit an unique mechanism of protein synthesis inhibition and generally display bacteriostatic activity against many important human pathogens, including methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and penicillin- and cephalosporin-resistant Streptococcus pneumoniae. Linezolid, the oxazolidinone which has been selected for clinical development, has near complete oral bioavailability plus favourable pharmacokinetic and toxicity profiles. Results from experimental models of infection and phase II trials reveal linezolid to be highly active in vivo against infections due to many common Gram-positive pathogens. The role of linezolid remains to be determined in phase III clinical trials, but it shows great promise as an alternative to glycopeptides and streptogramins to treat serious infections due to resistant Gram-positive organisms. Further modification of the oxazolidinone nucleus may yield agents with even greater potency and with novel spectra of activity.Keywords
This publication has 59 references indexed in Scilit:
- Vancomycin‐Resistant EnterococciClinical Infectious Diseases, 1998
- Synthesis and Antibacterial Activity of U-100592 and U-100766, Two Oxazolidinone Antibacterial Agents for the Potential Treatment of Multidrug-Resistant Gram-Positive Bacterial InfectionsJournal of Medicinal Chemistry, 1996
- Antimicrobial Activity of SCH 27899, Oligosaccharide Member of the Everninomycin Class with a Wide Gram-Positive SpectrumClinical Microbiology & Infection, 1995
- In-vitro activity of oxazolidinones against Mycobacterium avium ComplexJournal of Antimicrobial Chemotherapy, 1995
- Emerging multiply resistant enterococci among clinical isolates I. Prevalence data from 97 medical center surveillance study in the United StatesDiagnostic Microbiology and Infectious Disease, 1995
- Oxazolidinones, a new class of synthetic antituberculosis agent in vitro and in vivo activities of DuP-721 against Mycobacterium tuberculosisDiagnostic Microbiology and Infectious Disease, 1991
- Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1989The American Journal of Medicine, 1991
- Activity and mechanism of action of DuP 105 and DuP 721, new oxazolidinone compoundsJournal of Antimicrobial Chemotherapy, 1988
- Emergence of Vancomycin Resistance in Coagulase-Negative StaphylococciNew England Journal of Medicine, 1987
- Quantitative Action of Penicillin Inhibitor from Penicillin-Resistant Strains of StaphylococciScience, 1945